ResMed Inc.
RMD
$245.73
-$13.29-5.13%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.40B | 5.26B | 5.15B | 5.02B | 4.93B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.40B | 5.26B | 5.15B | 5.02B | 4.93B |
| Cost of Revenue | 2.08B | 2.07B | 2.06B | 2.04B | 2.02B |
| Gross Profit | 3.32B | 3.19B | 3.09B | 2.98B | 2.91B |
| SG&A Expenses | 1.05B | 1.01B | 991.02M | 968.08M | 952.70M |
| Depreciation & Amortization | 78.98M | 78.09M | 77.39M | 75.34M | 76.02M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.55B | 3.49B | 3.46B | 3.41B | 3.37B |
| Operating Income | 1.85B | 1.76B | 1.69B | 1.61B | 1.56B |
| Income Before Tax | 1.82B | 1.74B | 1.68B | 1.58B | 1.53B |
| Income Tax Expenses | 332.81M | 302.96M | 276.84M | 263.99M | 286.27M |
| Earnings from Continuing Operations | 1.49K | 1.44K | 1.40K | 1.31K | 1.25K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.49B | 1.44B | 1.40B | 1.31B | 1.25B |
| EBIT | 1.85B | 1.76B | 1.69B | 1.61B | 1.56B |
| EBITDA | 2.02B | 1.94B | 1.86B | 1.76B | 1.71B |
| EPS Basic | 10.16 | 9.81 | 9.55 | 8.94 | 8.50 |
| Normalized Basic EPS | 7.94 | 7.57 | 7.20 | 6.81 | 6.55 |
| EPS Diluted | 10.11 | 9.77 | 9.51 | 8.91 | 8.47 |
| Normalized Diluted EPS | 7.91 | 7.54 | 7.17 | 6.78 | 6.52 |
| Average Basic Shares Outstanding | 585.22M | 586.18M | 586.86M | 587.31M | 587.55M |
| Average Diluted Shares Outstanding | 587.53M | 588.64M | 589.34M | 589.83M | 590.06M |
| Dividend Per Share | 2.26 | 2.19 | 2.12 | 2.07 | 2.02 |
| Payout Ratio | 22.25% | 22.31% | 22.19% | 23.14% | 23.76% |